FTC looks into ads for genetic tests

Share this article:
The Federal Trade Commission has opened an investigation into the possible deceptive advertising and marketing of DTC genetic tests, according to The New York Times, which cited an FTC official speaking at a June 12 meeting convened by Sen. Gordon Smith (R-OR). 

Earlier in June, the AMA's House of Delegates adopted a resolution calling for more regulation of advertising by the industry, while California sent cease and desist letters to 13 companies that offer consumer genetic tests, demanding they stop testing until they can prove that their labs are licensed and that the tests were ordered by physicians, not patients. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.